phosphorylcholine has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alsayed, Y; Anderson, J; Anderson, KC; Ghobrial, IM; Hatjiharissi, E; Hideshima, T; Huston, A; Jia, X; Leleu, X; Moreau, AS; Munshi, N; Ngo, HT; Richardson, P; Roccaro, A; Roodman, DG; Runnels, J; Sportelli, P; Tai, YT; Vallet, S | 1 |
1 other study(ies) available for phosphorylcholine and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
Article | Year |
---|---|
Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment.
Topics: Benzoquinones; Bone Marrow; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; DNA Replication; Flow Cytometry; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Multiple Myeloma; Phosphorylcholine; Proto-Oncogene Proteins c-akt | 2008 |